Medications

Prescription drug price battles show no sign of letting up

The decision this week by experts at the Food and Drug Administration to endorse a pair of medicines aimed at combating heart disease brought on the latest round of hand-wringing over prescription drug costs.

Vaccination

China's bet on homegrown mRNA vaccines holds back nation

China is trying to navigate its biggest coronavirus outbreak without a tool it could have adopted many months ago, the kind of vaccines that have proven to offer the best protection against the worst outcomes from COVID-19.

Health

Need to see a psychiatrist? Call your insurance company first

Last week, a patient contacted me to find a psychiatrist because his anxiety was beginning to get out of control. He wanted to see someone who could do therapy and prescribe medications if he needed them. I gave him some ...

Medical economics

Brand drug discount cards increase private insurer costs by 46%

Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).

Health

Insurers speed health care overhaul preparations

(AP) -- The nation's big insurers are spending millions to carry out President Barack Obama's health care overhaul even though there's a chance the wide-reaching law won't survive Supreme Court scrutiny.

Health

U.S. gives states more time to set up health insurance exchanges

(HealthDay)—The Obama administration is giving states additional time to set up so-called health insurance exchanges, a key element of the 2010 health reform law designed to bring coverage to an estimated 30 million Americans ...

Oncology & Cancer

Lung cancer screening might pay off, analysis shows

(HealthDay) -- Screening people at high risk for lung cancer could be at least as cost-effective as screening for breast, colorectal and cervical cancers, a new study suggests.

page 3 from 8